Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Barbara Lupo
Observed names:
B Lupo,
B. Lupo,
Lupo, Barbara
Institutions:
Candiolo Cancer Institute,
University of Turin
Observed institutions:
German Cancer Research Center,
University of Milan,
Mimetas (Netherlands),
Azienda Ospedaliero Universitaria San Giovanni Battista,
Candiolo Cancer Institute,
Istituti di Ricovero e Cura a Carattere Scientifico,
University of Turin
show all 7
ORCID:
0000-0002-4383-6882
Observed ORCID:
0000-0002-4383-6882
OpenAlex ID:
A5082657058
The genomic landscape of response to EGFR blockade in colorectal cancer
2015
·
Andrea Bertotti
, Eniko Papp
, et al.
·
Nature
·
503
Inhibition of poly(ADP-ribosyl)ation in cancer: Old and new paradigms revisited
2014
·
Barbara Lupo
, Livio Trusolino
·
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
·
148
IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies
2015
·
Eugenia R. Zanella
, Francesco Galimi
, et al.
·
Science Translational Medicine
·
132
PDF
Colorectal cancer residual disease at maximal response to EGFR blockade displays a druggable Paneth cell–like phenotype
2020
·
Barbara Lupo
, Francesco Sassi
, et al.
·
Science Translational Medicine
·
84
The Plasma Membrane Sialidase NEU3 Regulates the Malignancy of Renal Carcinoma Cells by Controlling β1 Integrin Internalization and Recycling
2012
·
Cristina Tringali
, Barbara Lupo
, et al.
·
Journal of Biological Chemistry
·
76
PDF
Stem cell mobilization in patients with newly diagnosed multiple myeloma after lenalidomide induction therapy
2011
·
F Cavallo
, S Bringhen
, et al.
·
Leukemia
·
67
RETRACTED ARTICLE: Silencing of membrane-associated sialidase Neu3 diminishes apoptosis resistance and triggers megakaryocytic differentiation of chronic myeloid leukemic cells K562 through the increase of ganglioside GM3
2008
·
C Tringali
, B Lupo
, et al.
·
Cell Death and Differentiation
·
56
Expression of Sialidase Neu2 in Leukemic K562 Cells Induces Apoptosis by Impairing Bcr-Abl/Src Kinases Signaling
2007
·
Cristina Tringali
, Barbara Lupo
, et al.
·
Journal of Biological Chemistry
·
56
PDF
Phosphoproteomics of patient-derived xenografts identifies targets and markers associated with sensitivity and resistance to EGFR blockade in colorectal cancer
2023
·
Robin Beekhof
, Andrea Bertotti
, et al.
·
Science Translational Medicine
·
39
PDF
Sialidase NEU4 is involved in glioblastoma stem cell survival
2014
·
I Silvestri
, F Testa
, et al.
·
Cell Death and Disease
·
36
PDF
Rebound Effects Caused by Withdrawal of MET Kinase Inhibitor Are Quenched by a MET Therapeutic Antibody
2016
·
Emanuela Pupo
, Nadia Ducano
, et al.
·
Cancer Research
·
29
PDF
NEU4L sialidase overexpression promotes β‐catenin signaling in neuroblastoma cells, enhancing stem‐like malignant cell growth
2012
·
Cristina Tringali
, Federica Cirillo
, et al.
·
International Journal of Cancer
·
25
PDF
XENTURION is a population-level multidimensional resource of xenografts and tumoroids from metastatic colorectal cancer patients
2024
·
Simonetta M. Leto
, Elena Grassi
, et al.
·
Nature Communications
·
24
PDF
Tankyrase inhibition impairs directional migration and invasion of lung cancer cells by affecting microtubule dynamics and polarity signals
2016
·
Barbara Lupo
, Jorge Vialard
, et al.
·
BMC Biology
·
24
PDF
Melphalan/Prednisone/Lenalidomide (MPR) Versus High-Dose Melphalan and Autologous Transplantation (MEL200) in Newly Diagnosed Multiple Myeloma (MM) Patients <65 Years: Results of a Randomized Phase III Study
2011
·
Antonio Palumbo
, Federica Cavallo
, et al.
·
Blood
·
24
Multi-label transcriptional classification of colorectal cancer reflects tumor cell population heterogeneity
2023
·
Silvia Cascianelli
, Chiara Barbera
, et al.
·
Genome Medicine
·
23
PDF
Melphalan/prednisone/lenalidomide (MPR) versus high-dose melphalan and autologous transplantation (MEL200) in newly diagnosed multiple myeloma (MM) patients: A phase III trial.
2011
·
M. Boccadoro
, F. Cavallo
, et al.
·
Journal of Clinical Oncology
·
18
A Prospective, Randomized Study of Melphalan, Prednisone, Lenalidomide (MPR) versus Melphalan (200 Mg/M2) and Autologous Transplantation (Mel200) in Newly Diagnosed Myeloma Patients: An Interim Analysis.
2009
·
Antonio Palumbo
, Federica Cavallo
, et al.
·
Blood
·
17
Heterogeneity and evolution of DNA mutation rates in microsatellite stable colorectal cancer
2025
·
Elena Grassi
, Valentina Vurchio
, et al.
·
Science Translational Medicine
·
11
PDF
Acidosis overrides molecular heterogeneity to shape therapeutically targetable metabolic phenotypes in colon cancers
2025
·
Elena Richiardone
, Maria Virginia Giolito
, et al.
·
Cancer Letters
·
11
A Phase III Study of Enoxaparin Vs Aspirin as Thromboprophylaxis for Newly Diagnosed Myeloma Patients Treated with Lenalidomide-Based Regimen.
2010
·
Federica Cavallo
, Francesco Di Raimondo
, et al.
·
Blood
·
11
The Molecular and Functional Landscape of Resistance to FOLFIRI Chemotherapy in Metastatic Colorectal Cancer
2025
·
Marco Avolio
, Simonetta M. Leto
, et al.
·
Cancer Discovery
·
9
Repurposed AT9283 triggers anti-tumoral effects by targeting MKK3 oncogenic functions in Colorectal Cancer
2024
·
Valentina Piastra
, Federica Ganci
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
6
PDF
Abstract 1081: Genome-wide CRISPR screens reveal Hippo pathway activation as a resistance mechanism in BRAF mutant colon cancer
2021
·
Jonathan S. Brammeld
, Hannah Thorpe
, et al.
·
Cancer Research
·
3
Lenalidomide in the Treatment of Young Patients with Multiple Myeloma: From Induction to Consolidation/Maintenance Therapy
2012
·
Barbara Lupo
, Antonio Palumbo
·
Advances in Hematology
·
3
PDF
Show more works
View as search
Works count:
149
Citation count:
1,449
H-index:
17
I10-index:
21
Year
Topic
Type